| 1 |
32239671 | Metformin inhibition of colorectal cancer cell migration is associated with rebuilt adherens junctions and FAK downregulation. | 2020 Nov |
3 |
| 2 |
32627027 | Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. | 2020 Jul |
1 |
| 3 |
30625181 | Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells. | 2019 |
1 |
| 4 |
31939444 | Metformin enhances radiosensitivity in hepatocellular carcinoma by inhibition of specificity protein 1 and epithelial-to-mesenchymal transition. | 2019 |
1 |
| 5 |
29396886 | Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma. | 2018 Apr |
1 |
| 6 |
30017802 | The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC). | 2018 Sep 5 |
2 |
| 7 |
30067448 | Antidiabetic drugs influence molecular mechanisms in prostate cancer. | 2018 |
1 |
| 8 |
28043910 | Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis. | 2017 Mar 28 |
1 |
| 9 |
28334027 | Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner. | 2017 |
1 |
| 10 |
28744307 | Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II. | 2017 |
1 |
| 11 |
26892736 | The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling. | 2016 Apr |
1 |
| 12 |
27073581 | The impact of metformin and salinomycin on transforming growth factor β-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell lines. | 2016 Apr |
1 |
| 13 |
27534967 | Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter. | 2016 Dec |
5 |
| 14 |
27643646 | Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines. | 2016 Sep |
4 |
| 15 |
28002460 | Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice. | 2016 |
1 |
| 16 |
25854169 | Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway. | 2015 Aug |
1 |
| 17 |
26260219 | Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models. | 2015 Oct |
1 |
| 18 |
24935589 | Cisplatin combined with metformin inhibits migration and invasion of human nasopharyngeal carcinoma cells by regulating E-cadherin and MMP-9. | 2014 |
2 |
| 19 |
25201727 | Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4. | 2014 Sep 26 |
1 |
| 20 |
21088486 | Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis. | 2010 Nov 15 |
1 |